Evidence map›Paper›PMID 30988334›Full record

ArticleScientific reports2019

Cardiac inflammatory CD11b/c cells exert a protective role in hypertrophied cardiomyocyte by promoting TNFR

Mathilde Keck, Mathilde Flamant, Nathalie Mougenot, Sophie Favier, Fabrice Atassi, Camille Barbier, Sophie Nadaud, Anne-Marie Lompré, Jean-Sébastien Hulot, Catherine Pavoine

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.6field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. The Effect of TNF-Cardiology research and practice · 2022
    Review
  7. Article
  8. Article
  9. Article
  10. Frontiers in physiology · 2021
    Review
  11. Article
  12. Complexity of TNF-α Signaling in Heart Disease.Journal of clinical medicine · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Mathilde KeckSorbonne Universités, UPMC Univ Paris 06, INSERM, Institute of Cardiometabolism and Nutrition (ICAN), Team 3, F-75013, Paris, France.
Mathilde FlamantSorbonne Universités, UPMC Univ Paris 06, INSERM, Institute of Cardiometabolism and Nutrition (ICAN), Team 3, F-75013, Paris, France.
Nathalie MougenotSorbonne Universités, UPMC Univ Paris 06, INSERM, Institute of Cardiometabolism and Nutrition (ICAN), Team 3, F-75013, Paris, France.
Sophie FavierSorbonne Universités, UPMC Univ Paris 06, INSERM, Institute of Cardiometabolism and Nutrition (ICAN), Team 3, F-75013, Paris, France.
Fabrice AtassiSorbonne Universités, UPMC Univ Paris 06, INSERM, Institute of Cardiometabolism and Nutrition (ICAN), Team 3, F-75013, Paris, France.
Camille BarbierSorbonne Universités, UPMC Univ Paris 06, INSERM, Institute of Cardiometabolism and Nutrition (ICAN), Team 3, F-75013, Paris, France.
Sophie NadaudSorbonne Universités, UPMC Univ Paris 06, INSERM, Institute of Cardiometabolism and Nutrition (ICAN), Team 3, F-75013, Paris, France.ORCID http://orcid.org/0000-0002-1452-6009
Anne-Marie LompréSorbonne Universités, UPMC Univ Paris 06, INSERM, Institute of Cardiometabolism and Nutrition (ICAN), Team 3, F-75013, Paris, France.
Jean-Sébastien HulotSorbonne Universités, UPMC Univ Paris 06, INSERM, Institute of Cardiometabolism and Nutrition (ICAN), Team 3, F-75013, Paris, France.
Catherine PavoineSorbonne Universités, UPMC Univ Paris 06, INSERM, Institute of Cardiometabolism and Nutrition (ICAN), Team 3, F-75013, Paris, France. catherine.pavoine@inserm.fr.ORCID http://orcid.org/0000-0002-0598-5545
Inserm · FR

Funding

Role of STIM1 in cardiac hypertrophy and heart failureR01HL113497 · NHLBI · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI AKAR, FADI GABRIEL · 2012 to 2016
$2.1M
NHLBI NIH HHS R01 HL113497
6 · The paper itself

Abstract

Early adaptive cardiac hypertrophy (EACH) is initially a compensatory process to optimize pump function. We reported the emergence of Orai3 activity during EACH. This study aimed to characterize how inflammation regulates store-independent activation of Orai3-calcium influx and to evaluate the functional role of this influx. Isoproterenol infusion or abdominal aortic banding triggered EACH. TNFα or conditioned medium from cardiac CD11b/c cells activated either in vivo [isolated from rats displaying EACH], or in vitro [isolated from normal rats and activated with lipopolysaccharide], were added to adult cardiomyocytes before measuring calcium entry, cell hypertrophy and cell injury. Using intramyocardial injection of siRNA, Orai3 was in vivo knockdown during EACH to evaluate its protective activity in heart failure. Inflammatory CD11b/c cells trigger a store-independent calcium influx in hypertrophied cardiomyocytes, that is mimicked by TNFα. Pharmacological or molecular (siRNA) approaches demonstrate that this calcium influx, depends on TNFR

Indexed as

AnimalsCalciumCalcium ChannelsCardiomegalyCD11b AntigenCD11c AntigenCulture Media, ConditionedDisease Models, AnimalDisease ProgressionGene Knockdown TechniquesGlycogen Synthase Kinase 3 betaHeart FailureHumansIsoproterenolMaleMyocytes, CardiacCalciumCalcium ChannelsCD11b AntigenCD11c AntigenCulture Media, ConditionedGlycogen Synthase Kinase 3 betaGsk3b protein, ratIsoproterenolOrai3 protein, ratReceptors, Tumor Necrosis Factor, Type IIRNA, Small InterferingTumor Necrosis Factor-alpha

Identifiers

PMID30988334
PMCPMC6465256
OpenAlexW2936966185

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.